CHELSAE ELLIOTT: Open Payments
NPI 1518491141 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 11 payments from 7 companies in 2025. Trend: 2023 $76 · 2024 $113 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 3 | $60 |
| Astellas Pharma US Inc | 2 | $37 |
| Hologic Sales and Service, LLC | 2 | $36 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Organon LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
Products named: Veozah, APTIMA, INJECTAFER, NEXPLANON, Lynkuet, MYFEMBREE.
Industry payments across NV — which companies pay providers there.
